ALKS 5461

ALKS 5461

  • March 2019 •
  • 20 pages •
  • Report ID: 5807963 •
  • Format: PDF
ALKS 5461 (Alkermes) is a fixed-dose combination of buprenorphine, a mu opioid receptor partial agonist and kappa opioid receptor antagonist, and samidorphan (ALKS 33), which is a proprietary opioid modulator.